Showing results (11-20 of 773) with videos related to

Sort By:
Pageof 78
The American Journal of Cardiology|August 14, 2003
Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectorisAkshay S Desai, Daniel H Solomon, Peter H Stone, et al.
The American Journal of Medicine|December 25, 2003
Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?Daniel H Solomon, Sebastian Schneeweiss, Robert J Glynn, et al.
The Journal of Rheumatology|April 3, 2003
The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patientsDaniel H Solomon, Robert J Glynn, Rhonda Bohn, et al.
Medical Care|June 27, 2006
Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy reviewMichael A Fischer, Hailu Cheng, Sebastian Schneeweiss, et al.
Arthritis and Rheumatism|August 9, 2003
Arthritis self-management education programs: a meta-analysis of the effect on pain and disabilityAsra Warsi, Michael P LaValley, Philip S Wang, et al.
Archives of Internal Medicine|August 11, 2004
Self-management education programs in chronic disease: a systematic review and methodological critique of the literatureAsra Warsi, Philip S Wang, Michael P LaValley, et al.
Medical Care|October 25, 2007
Design of cluster-randomized trials of quality improvement interventions aimed at medical care providersRobert J Glynn, M Alan Brookhart, Margaret Stedman, et al.
Epidemiology (Cambridge, Mass.)|December 23, 2004
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarctionSebastian Schneeweiss, Robert J Glynn, Elizabeth H Tsai, et al.
Pharmacoepidemiology and Drug Safety|October 22, 2009
NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxibSebastian Schneeweiss, Robert J Glynn, Jerry Avorn, et al.
Arthritis and Rheumatism|April 29, 2006
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of riskDaniel H Solomon, Jerry Avorn, Til Stürmer, et al.
Pageof 78